Login / Signup

The impact of chronic kidney disease on outcomes following peripheral vascular intervention.

Dennis I NarcisseElizabeth Hope WeisslerJennifer A RymerEhrin J ArmstrongEric A SecemskyWilliam A GrayJihad A MustaphaGeorge L AdamsGary M AnselManesh R PatelWilliam Schuyler Jones
Published in: Clinical cardiology (2020)
Despite high procedural success and low amputation rates, patients with CKD remain at greater risk for MAVE and all-cause mortality after PVI. Further research is needed to determine treatment strategies to mitigate substantial mortality risk in this vulnerable population.
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • randomized controlled trial
  • lower limb
  • peripheral artery disease
  • chemotherapy induced